Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease

American Journal of Gastroenterology

Volumn 108, Issue 11, 2013, Pages 1775-1784

  Borrelli, Melissa ^a   Salvati, Virginia M ^b   Maglio, Mariantonia ^a   Zanzi, Delia ^a   Ferrara, Katia ^a   Santagata, Sara ^a   Ponticelli, Domenico ^a   Aitoro, Rosita ^a   Mazzarella, Giuseppe ^c   Lania, Giuliana ^a   Gianfrani, Carmen ^c   Auricchio, Renata ^a   Troncone, Riccardo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b S Maria DellaOlmo Hospital   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; RNA; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CELIAC DISEASE; CELL FUNCTION; CELL ISOLATION; CELLS; CHILD; COCULTURE; CONTROLLED STUDY; DISEASE ACTIVITY; DUODENUM BIOPSY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MARSH; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SEROLOGY; SMALL INTESTINE MUCOSA; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-15; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 84887234999     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.303     Document Type: Article

References (38)

1. Husby S, Koletzko S, Korponay-Szab ó IR et al. For the ESPGHAN Working Group on Coeliac Disease Diagnosis, on behalf of the ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-60.
2. Oberhuber G, Granditsch G, Vogelsang H et al. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-94. (Pubitemid 30433773)
3. Ferguson A, Arranz E, O ' Mahony S. Clinical and pathological spectrum of coeliac disease-active, silent, latent, potential. Gut 1993; 34: 150-1. (Pubitemid 23049101)
4. Ludvigsson JF, Leffl er DA, Bai JC et al. The Oslo defi nitions for coeliac disease and related terms. Gut 2012; 62: 43-52.
5. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009; 373: 1480-93.
6. Van de Wal Y, Kooy Y, Van Veelen P et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specifi c T cell reactivity. J Immunol 1998; 161: 1585-8. (Pubitemid 28387571)
7. Nilsen EM, Jahnsen FL, Lundin KEA et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551-63. (Pubitemid 28397290)
8. Salvati VM, MacDonald TT, Bajaj-Elliott M et al. Interleukin 18 and associated markers of T helper cell type 1 activity in celiac disease. Gut 2002; 50: 186-90. (Pubitemid 34087929)
9. Troncone R, Gianfrani C, Mazzarella G et al. Majority of gliadin-specifi c T-cell clones from celiac small intestinal mucosa produce interferongamma and interleukin-4. Dig Dis Sci 1998; 43: 156-61. (Pubitemid 28081656)
10. Meresse B, Ripoche J, Heyman M et al. Celiac disease: from oral tolerance to intestinal infl ammation, autoimmunity and lymphomagenesis. Mucosal Immunol 2009; 2: 8-23.
11. Maiuri L, Ciacci C, Ricciardelli I et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003; 362: 30-7. (Pubitemid 36835817)
12. Mention JJ, Ben Ahmed M, B è gue B et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003; 125: 730-45. (Pubitemid 37070691)
13. Salvati VM, Mazzarella G, Gianfrani C et al. Recombinant human interleukin 10 suppresses gliadin dependent T cell activacion in ex vivo cultured coeliac disease. Gut 2005; 54: 46-53. (Pubitemid 40007217)
14. Forsberg G, Hernell O, Hammastrom S et al. Concomitant increase of IL-10 and pro-infl ammatory cytokines in intraepithelial lymphocyte subsets in celiac disease. Int Immunol 2007; 19: 993-1001. (Pubitemid 47386924)
15. Vorobjova T, Uibo O, Heilman K et al. Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus. Scand J Gastroenterol 2009; 44: 422-30.
16. Zanzi D, Stefanile R, Santagata S et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease. Am J Gastroenterol 2011; 106: 1308-17.
17. Westerholm-Ormio M, Garioch J, Ketola I et al. Infl ammatory cytokines in small intestinal mucosa of patients with potential coeliac disease. Clin Exp Immunol 2002; 128: 94-101. (Pubitemid 34451185)
18. Tittanen M, Westerholm-ormio M, Verkasalo M et al. Infi ltration of forkhead box P3-expression cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes. Clin Exp Immunol 2008; 152: 498-507. (Pubitemid 351661513)
19. Working Group of ESPGHAN. Revised criteria for diagnosis of celiac disease. Arch Dis Child 1990; 65: 909-11.
20. Maglio M, Mazzarella G, Barone MV et al. Immunogenicity of two oat varieties, in relation to their safety for celiac patients. Scand J Gastroenterol 2011; 46: 1194-205.
21. Maiuri L, Ciacci C, Auricchio S et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000; 119: 996-1006.
22. Awasthi A, Murugaiyan G, Kuchroo VK. Interplay between effector Th17 and regulatory T cells. J Clin Immunol 2008; 28: 660-70.
23. Sperandeo MP, Tosco A, Izzo V et al. Potential celiac patients: a model of celiac disease pathogenesis. PLoS One 2011; 6: e21281.
24. Szabo SJ, Kim ST, Costa GL et al. A novel transcription factor, T-bet directs Th1 lineage commitment. Cell 2000; 100: 655-69.
25. Li B, Yang P, Chu L et al. T-bet expression in the iris and spleen parallels disease expression during endotoxin-induced uveitis. Graefes Arch Clin Exp Ophthalmol 2007; 245: 407-13. (Pubitemid 46404002)
26. Fina D, Sarra M, Caruso R et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 2008; 57: 887-92. (Pubitemid 351919521)
27. Salvati VM, MacDonald TT, Del Vecchio Blanco G et al. Enhanced expression of interferon regulatory factror-1 in the mucosa of children with celiac disease. Pediatr Res 2003; 54: 312-8. (Pubitemid 37013191)
28. Suk K, Kim YH, Kim KA et al. IFN-gamma/TNF-alpha synergism as the fi nal effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 patway in pancreatic beta cell death. J Immunol 2001; 166: 4481-9. (Pubitemid 32233732)
29. Nakazawa T, Satoh J, Takahashi K et al. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1. J Autoimmun 2001; 17: 119-25. (Pubitemid 32928207)
30. Kuhn R, Lohler J, Rennick D et al. Inteleukin-10 defi cient mice develop chronic enterocolitis. Cell 1993; 75: 263-74. (Pubitemid 23320290)
31. Glocker EO, Kotiarz D, Boztung K et al. Infl ammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361: 2033-45.
32. Powrie F, Leach MW, Mauze S et al. Inhibition of Th1 responses prevents infl ammatory bowel disease in scid mice reconstituted with CD45RBhi T cells. Immunity 1994; 1: 553-62.
33. Earle KE, Tang Q, Zhou X et al. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 2005; 115: 3-9. (Pubitemid 40616162)
34. Sakaguchi S, Ono M, Setoguchi R et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8-27. (Pubitemid 44116697)
35. Asseman C, Mauze S, Leach MW et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal infl ammation. J Exp Med 1999; 190: 995-1004.
36. Annacker O, Pimenta-Araujo R, Burlen-Defranoux O et al. CD25+CD4+T cells regulate the expansion of peripheral CD4T cell through the production of IL10. J Immunol 2001; 166: 3008-18. (Pubitemid 33117296)
37. Huber S, Gagliani N, Esplugues E et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3-and Foxp3+ regulatory CD4+ cells in an interleukin-10-dependent manner. Immunity 2011; 34: 554-65.
38. Murai M, Turovskaya O, Kim G et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009; 10: 1178-84.